Literature DB >> 26795360

Omalizumab Treatment of Vernal Keratoconjunctivitis.

Enrico Heffler1, Giuseppe Picardi1, Maria Teresa Liuzzo1, Maria Provvidenza Pistorio1, Nunzio Crimi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26795360     DOI： 10.1001/jamaophthalmol.2015.5679

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  8 in total

Review 1.  Emerging Therapeutics for Ocular Surface Disease.

Authors:  Leonard Bielory; Dovid Schoenberg
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-28       Impact factor: 4.806

Review 2.  Therapeutic Targets in Allergic Conjunctivitis.

Authors:  Bisant A Labib; DeGaulle I Chigbu
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-28

Review 3.  An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics.

Authors:  Roberto Bernardini; Gaia Toschi Vespasiani; Arianna Giannetti
Journal:  Medicina (Kaunas)       Date:  2022-04-29       Impact factor: 2.948

Review 4.  Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia.

Authors:  Rohan Bir Singh; Lingjia Liu; Ann Yung; Sonia Anchouche; Sharad K Mittal; Tomas Blanco; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2021-05-15       Impact factor: 6.268

5.  Omalizumab in Severe Refractory Vernal Keratoconjunctivitis in Children: Case Series and Review of the Literature.

Authors:  Serge Doan; Flore Amat; Eric Gabison; Sarah Saf; Isabelle Cochereau; Jocelyne Just
Journal:  Ophthalmol Ther       Date:  2016-12-01

6.  Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score.

Authors:  Andrea Leonardi; Maëva Dupuis-Deniaud; Dominique Bremond-Gignac
Journal:  J Mark Access Health Policy       Date:  2020-04-04

7.  Neuronal FcεRIα directly mediates ocular itch via IgE-immune complex in a mouse model of allergic conjunctivitis.

Authors:  Huan Cui; Fan Liu; Yehong Fang; Tao Wang; Bo Yuan; Chao Ma
Journal:  J Neuroinflammation       Date:  2022-02-23       Impact factor: 8.322

8.  Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years.

Authors:  Soyang Ella Kim; Victoria Nowak; Ana Quartilho; Frank Larkin; Melanie Hingorani; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2020-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.